JOHN HOPE FRANKLIN CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Duke University
- Target Recruit Count
- 64
- Registration Number
- NCT00615927
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2014-08-18
- Lead Sponsor
- Duke University
- Target Recruit Count
- 41
- Registration Number
- NCT00616005
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Genetics of Peripheral Artery Genomics
Completed
- Conditions
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2016-01-25
- Lead Sponsor
- Duke University
- Target Recruit Count
- 122
- Registration Number
- NCT00615121
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 37
- Registration Number
- NCT00612651
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2013-07-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 23
- Registration Number
- NCT00613028
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Treatment of Mood and Marriage Study (TOMMS)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 42
- Registration Number
- NCT00612807
- Locations
- 🇺🇸
Duke Child & Family Studies Center; Duke University Medical Center, Durham, North Carolina, United States
Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Duke University
- Target Recruit Count
- 96
- Registration Number
- NCT00612638
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 42
- Registration Number
- NCT00612989
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2014-07-09
- Lead Sponsor
- Duke University
- Target Recruit Count
- 67
- Registration Number
- NCT00613093
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Duke University
- Target Recruit Count
- 41
- Registration Number
- NCT00612339
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
© Copyright 2024. All Rights Reserved by MedPath